CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue
Total revenue, net	$ 3,108	$ 2,813	$ 8,180	$ 7,461
Operating expenses
Cost of product revenue	541	514	1,398	1,350
Research and development	4,043	6,081	12,008	15,133
Sales and marketing	2,010	1,472	4,977	4,929
General and administrative	3,776	3,533	12,471	12,783
Total operating expenses	10,370	11,600	30,854	34,195
Loss from operations	(7,262)	(8,787)	(22,674)	(26,734)
Interest income (expense)	162	(500)	(341)	(6,134)
Changes in fair value of freestanding and hybrid financial instruments designated at Fair Value Option	(3,089)	(2,244)	(6,920)	(3,365)
Gain on extinguishment of debt		3,697	1,245	3,697
Other income (expense)	168	(70)	(327)	(56)
Loss before income tax expense	(10,021)	(7,904)	(29,017)	(32,592)
Income tax expense		0	0	0
Net loss	(10,021)	(7,904)	(29,017)	(32,592)
Net loss attributable to noncontrolling interest	(167)	(126)	(445)	(462)
Net loss attributable to common stockholders	$ (9,854)	$ (7,778)	$ (28,572)	$ (32,130)
Net loss per share, basic	$ (1.05)	$ (22.5)	$ (4.89)	$ (132.49)
Net loss per share, diluted	$ (1.05)	$ (22.5)	$ (4.89)	$ (132.49)
Weighted-average common stock outstanding, basic	9,370,136	345,657	5,848,903	242,504
Weighted-average common stock outstanding, diluted	9,370,136	345,657	5,848,903	242,504
Product revenue, net
Revenue
Total revenue, net	$ 3,066	$ 2,813	$ 8,095	$ 7,461
License revenue
Revenue
Total revenue, net	$ 42		$ 85